0001551986-19-000024.txt : 20190401 0001551986-19-000024.hdr.sgml : 20190401 20190401165112 ACCESSION NUMBER: 0001551986-19-000024 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190401 DATE AS OF CHANGE: 20190401 EFFECTIVENESS DATE: 20190401 FILER: COMPANY DATA: COMPANY CONFORMED NAME: INNOVATE BIOPHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001551986 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-336185 FILM NUMBER: 19721420 BUSINESS ADDRESS: STREET 1: 8480 HONEYCUTT ROAD STREET 2: SUITE 120 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: 919-275-1933 MAIL ADDRESS: STREET 1: 8480 HONEYCUTT ROAD STREET 2: SUITE 120 CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: Monster Digital, Inc. DATE OF NAME CHANGE: 20150930 FORMER COMPANY: FORMER CONFORMED NAME: Tandon Digital, Inc. DATE OF NAME CHANGE: 20120611 D 1 primary_doc.xml X0708 D LIVE 0001551986 INNOVATE BIOPHARMACEUTICALS, INC. 8480 HONEYCUTT ROAD SUITE 120 RALEIGH NC NORTH CAROLINA 27615 919-275-1933 DELAWARE Monster Digital, Inc. Tandon Digital, Inc. Corporation true Sandeep Laumas 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Executive Officer Director Jay Madan 8480 Honeycutt Road Suite 120 Raleigh NJ NEW JERSEY 27615 Executive Officer Director Anthony Maida 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Lorin Johnson 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Saira Ramasastry 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Roy Proujansky 8480 Honeycutt Road Suite 120 Raleigh NC NORTH CAROLINA 27615 Director Pharmaceuticals Decline to Disclose 06b false 2019-03-18 false true true false 0 9741900 9741900 0 Represents warrants to purchase up to 4,181,068 shares of common stock at an exercise price of $4.00 per share and up to 2,508,641 shares of common stock at an exercise price of $2.56 per share, issued to certain investors in a registered equity offering. false 17 0 0 0 false INNOVATE BIOPHARMACEUTICALS, INC. /s/ Jay Madan Jay Madan Chief Business Officer 2019-04-01